Company profile
Replimune Group, Inc. Insider Trading
REPLEvery SEC Form 4 insider trading filing for Replimune Group, Inc. (REPL) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001737953
- Filings
- 118
- Insiders
- 26
- Last filing
- 2026-08-20
Activity summary
No insider transactions in the last 30 days. The most recent was on August 20, 2026, when Philip Astley-Sparke reported 50,000 shares (Gift). 118 filings from 26 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Replimune Group, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $33.0M.
90 day insight
Over the last 90 days, Replimune Group, Inc. insiders bought $33.0M (2 transactions) and sold $1.0M (5 transactions).
- Most active insider: BAKER BROS. ADVISORS LP with 2 transactions totaling $33.0M.
- Largest single purchase: $31.5M by BAKER BROS. ADVISORS LP on Aug 11, 2026.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Philip Astley-Sparke | REPL | Gift | 50,000 | — | — |
| Aug 17, 2026 | Emily Luisa Hill | REPL | Sale | 9,256 | $14.28 | $132K |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | REPL | Purchase | 126,394 | $12.06 | $1.52M |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | REPL | Purchase | 2,609,946 | $12.06 | $31.48M |
| Aug 10, 2026 | Andrew Schwendenman | REPL | Sale | 7,632 | $12.97 | $99K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=REPL" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Replimune Group, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →